Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (3): 825-831.doi: 10.13481/j.1671-587X.20220334
• Review • Previous Articles Next Articles
Progress research in role of TLRs signaling pathway and Cross- talk of TLRs in inflammatory diseases
-
Received:2021-03-11Online:2022-05-28Published:2022-06-21
CLC Number:
- R392.19
Cite this article
share this article
| 1 | LIU Q， DING J L. The molecular mechanisms of TLR-signaling cooperation in cytokine regulation［J］. Immunol Cell Biol， 2016， 94（6）： 538-542. |
| 2 | YANG J L， WISE L， FUKUCHI K I. TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer’s disease［J］. Front Immunol， 2020， 11： 724. |
| 3 | GAUDINO S J， KUMAR P. Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis， bacterial infections， and tumorigenesis［J］. Front Immunol， 2019， 10： 360. |
| 4 | HIRSCH I， JANOVEC V， STRANSKA R， et al. Cross talk between inhibitory immunoreceptor tyrosine-based activation motif-signaling and toll-like receptor pathways in macrophages and dendritic cells［J］. Front Immunol， 2017， 8： 394. |
| 5 | TAN R S， HO B， LEUNG B P， et al. TLR cross-talk confers specificity to innate immunity［J］. Int Rev Immunol， 2014， 33（6）： 443-453. |
| 6 | EL-ACHKAR T M， DAGHER P C. Renal Toll-like receptors： recent advances and implications for disease［J］.Nat Clin Pract Nephrol，2006，2（10）： 568-581. |
| 7 | SEYA T， FUNAMI K， TANIGUCHI M， et al. Antibodies against human Toll-like receptors （TLRs）： TLR distribution and localization in human dendritic cells［J］. J Endotoxin Res， 2005， 11（6）： 369-374. |
| 8 | WERLING D， JANN O C， OFFORD V， et al. Variation matters： TLR structure and species-specific pathogen recognition［J］. Trends Immunol，2009，30（3）： 124-130. |
| 9 | RADONS J， DOVE S， NEUMANN D， et al. The interleukin 1 （IL-1） receptor accessory protein Toll/IL-1 receptor domain： analysis of putative interaction sites in vitro mutagenesis and molecular modeling［J］. J Biol Chem， 2003， 278（49）： 49145-49153. |
| 10 | NARAYANAN K B， PARK H H. Toll/interleukin-1 receptor （TIR） domain-mediated cellular signaling pathways［J］. Apoptosis， 2015， 20（2）： 196-209. |
| 11 | O’NEILL L A J. When signaling pathways collide： positive and negative regulation of toll-like receptor signal transduction［J］. Immunity， 2008， 29（1）： 12-20. |
| 12 | WONG D V T， LIMA-JÚNIOR R C P， CARVALHO C B M， et al. The adaptor protein Myd88 is a key signaling molecule in the pathogenesis of irinotecan-induced intestinal mucositis［J］.PLoS One，2015，10（10）： e0139985. |
| 13 | JIN H， WANG Y P， WANG D， et al. Effects of Qingshen granules on the oxidative stress-NF/kB signal pathway in unilateral ureteral obstruction rats［J］. Evid Based Complement Alternat Med， 2018，2018： 4761925. |
| 14 | BUCHHOLZ B M， BILLIAR T R， BAUER A J. Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus［J］. Am J Physiol Gastrointest Liver Physiol， 2010， 299（2）： G531-G538. |
| 15 | BAGCHI A， HERRUP E A， WARREN H S， et al. MyD88-dependent and MyD88-independent pathways in synergy， priming， and tolerance between TLR agonists［J］. J Immunol， 2007， 178（2）： 1164-1171. |
| 16 | JIANG S， LI X Y， HESS N J， et al. TLR10 is a negative regulator of both MyD88-dependent and-independent TLR signaling［J］. J Immunol， 2016， 196（9）： 3834-3841. |
| 17 | OHNISHI H， TOCHIO H， KATO Z， et al. 1H， 13C， and 15N resonance assignment of the TIR domain of human MyD88［J］. Biomol NMR Assign， 2010， 4（2）： 123-125. |
| 18 | WANG Q， DZIARSKI R， KIRSCHNING C J， et al. Micrococci and peptidoglycan activate TLR2： >MyD88： >IRAK： >TRAF： >NIK： >IKK： >NF-kappaB signal transduction pathway that induces transcription of interleukin-8［J］.Infect Immun，2001，69（4）：2270-2276. |
| 19 | TAKEUCHI O， HOSHINO K， AKIRA S. Cutting edge： TLR2-deficient and MyD88-deficient mice are highly susceptible toStaphylococcus aureusInfection［J］. J Immunol， 2000， 165（10）： 5392-5396. |
| 20 | QIN C Q， ZHANG B， ZHANG L， et al. MyD88-dependent Toll-like receptor 4 signal pathway in intervertebral disc degeneration［J］. Exp Ther Med， 2016， 12（2）： 611-618. |
| 21 | HOEBE K， DU X， GEORGEL P， et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling［J］. Nature， 2003， 424（6950）： 743-748. |
| 22 | KAWAI T， AKIRA S.TLR signaling［J］. Cell Death Differ，2006， 13（5）： 816-825. |
| 23 | MOGENSEN T H， PALUDAN S R， KILIAN M，et al. Two neisseria meningitidis strains with different ability to stimulate Toll-like receptor 4 through the MyD88-independent pathway［J］. Scand J Immunol， 2006， 64（6）： 646-654. |
| 24 | BROWN J， WANG H， HAJISHENGALLIS G N， et al. TLR-signaling networks： an integration of adaptor molecules， kinases， and cross-talk［J］. J Dent Res， 2011， 90（4）： 417-427. |
| 25 | TAN R S， HO B， LEUNG B P， et al. TLR cross-talk confers specificity to innate immunity［J］. Int Rev Immunol， 2014， 33（6）： 443-453. |
| 26 | SONG W C. Crosstalk between complement and Toll-like receptors［J］. Toxicol Pathol，2012，40（2）： 174-182. |
| 27 | MVAN EGMOND， VIDARSSON G， BAKEMA J E. Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity［J］. Immunol Rev， 2015， 268（1）： 311-327. |
| 28 | WIGREN M， NILSSON J， KAPLAN M J. Pathogenic immunity in systemic lupus erythematosus and atherosclerosis： common mechanisms and possible targets for intervention［J］. J Intern Med， 2015，278（5）： 494-506. |
| 29 | KOMATSUDA A， WAKUI H， IWAMOTO K， et al. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus［J］. Clin Exp Immunol， 2008， 152（3）： 482-487. |
| 30 | YOUNG N A， WU L C， BURD C J， et al. Estrogen modulation of endosome-associated toll-like receptor 8： an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus［J］. Clin Immunol， 2014， 151（1）： 66-77. |
| 31 | FINZEL S， SCHAFFER S， RIZZI M， et al. Pathogenesis of systemic lupus erythematosus［J］. Z Rheumatol， 2018， 77（9）： 789-798. |
| 32 | THORLACIUS G E， WAHREN-HERLENIUS M， RÖNNBLOM L. An update on the role of type Ⅰinterferons in systemic lupus erythematosus and Sjögren's syndrome［J］. Curr Opin Rheumatol， 2018， 30（5）： 471-481. |
| 33 | DU S W， JACOBS H M， ARKATKAR T， et al. Integrated B cell， Toll-like， and BAFF receptor signals promote autoantibody production by transitional B cells［J］. J Immunol， 2018， 201（11）： 3258-3268. |
| 34 | MALKIEL S， BARLEV A N， ATISHA-FREGOSO Y，et al. Plasma cell differentiation pathways in systemic lupus erythematosus［J］. Front Immunol， 2018， 9： 427. |
| 35 | DAS A， HEESTERS B A， BIALAS A， et al. Follicular dendritic cell activation by TLR ligands promotes autoreactive B cell responses［J］. Immunity， 2017， 46（1）： 106-119. |
| 36 | MAJER O， LIU B， KREUK L S M， et al. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity［J］. Nature， 2019， 575（7782）： 366-370. |
| 37 | FAN J. TLR cross-talk mechanism of hemorrhagic shock-primed pulmonary neutrophil infiltration［J］. Open Crit Care Med J， 2010， 2： 1-8. |
| 38 | FAN J， LI Y H， VODOVOTZ Y， et al. Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages： role in hemorrhage-primed lung inflammation［J］. Am J Physiol Lung Cell Mol Physiol， 2006， 290（4）： L738-L746. |
| 39 | GROEMPING Y， RITTINGER K. Activation and assembly of the NADPH oxidase： a structural perspective［J］. Biochem J， 2005， 386（Pt 3）： 401-416. |
| 40 | LI R T， SHANG Y， YU Y， et al. High-mobility group box 1 protein participates in acute lung injury by activating protein kinase R and inducing M1 polarization［J］. Life Sci， 2020， 246： 117415. |
| 41 | DING X B， JIN S Q， TONG Y， et al. TLR4 signaling induces TLR3 up-regulation in alveolar macrophages during acute lung injury［J］. Sci Rep， 2017， 7： 34278. |
| 42 | GREENHILL C J， ROSE-JOHN S， LISSILAA R， et al. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3［J］. J Immunol， 2011， 186（2）： 1199-1208. |
| 43 | MELLETT M， ATZEI P， BERGIN R， et al. Orphan receptor IL-17RD regulates Toll-like receptor signalling via SEFIR/TIR interactions［J］. Nat Commun， 2015， 6： 6669. |
| 44 | HUBER-LANG M， BARRATT-DUE A， PISCHKE S E， et al. Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice［J］. J Immunol， 2014， 192（11）： 5324-5331. |
| 45 | YU X F， YI H F， GUO C Q， et al. Pattern recognition scavenger receptor CD204 attenuates toll-like receptor 4-induced NF-κB activation by directly inhibiting ubiquitination of tumor necrosis factor （TNF） receptor-associated factor 6［J］. J Biol Chem， 2011， 286（21）： 18795-18806. |
| 46 | ZHOU H T， COVENEY A P， WU M， et al. Activation of both TLR and NOD signaling confers host innate immunity-mediated protection against microbial infection［J］. Front Immunol， 2019， 9： 3082. |
| 47 | YANG X M， JIANG X W， CHEN G J， et al. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response［J］. J Immunol， 2013， 190（5）： 2068-2079. |
| 48 | KUMAR V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury［J］. Front Immunol， 2020， 11： 1722. |
| No related articles found! |
|